Adia Nutrition Inc. (OTCQB: ADIA) reported significant business milestones and financial results for 2025. The company achieved a successful uplisting from OTC Pink to the OTCQB Venture Market in six weeks and completed SEC Rule 15c2-11 compliance. Preliminary and confirmed Q3 results indicated revenue growth of over 200% quarter-over-quarter, with earlier reports showing more than 100% growth and profit margins exceeding 20%. The sales force was tripled, and four regional sales divisions were established. Adia became a preferred vendor for the PI Doctors Elite Community, gaining access to over 4,000 personal injury physicians and the $50 billion personal injury care market. The company launched a national television marketing campaign and divested its Biolete Coffee subsidiary while retaining an 18% equity stake. Adia also progressed in negotiations for in-network status with major insurance providers and filed an SEC Form 10, with Nasdaq uplisting approval expected in early 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adia Nutrition Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 279037) on December 29, 2025, and is solely responsible for the information contained therein.